Literature DB >> 3619228

Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619228

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.

Authors:  Robin George Manappallil; Durga Prasan; Jayameena Peringat; Illolil Kuniyil Biju
Journal:  BMJ Case Rep       Date:  2018-06-05

2.  The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.

Authors:  T S Tracy; K Krohn; D R Jones; J D Bradley; S D Hall; D C Brater
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

Authors:  A Wollner; J Mohle-Boetani; R E Lambert; J L Perruquet; T A Raffin; J L McGuire
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

Review 4.  Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.

Authors:  Jirí Grim; Jaroslav Chládek; Jirina Martínková
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 7.  Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Authors:  Przemysław Koźmiński; Paweł Krzysztof Halik; Raphael Chesori; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.